Xponance Inc. Sells 13,270 Shares of Centene Co. (NYSE:CNC)

Xponance Inc. decreased its holdings in Centene Co. (NYSE:CNCFree Report) by 13.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 82,231 shares of the company’s stock after selling 13,270 shares during the period. Xponance Inc.’s holdings in Centene were worth $4,982,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Capital Advisors Ltd. LLC raised its stake in Centene by 75.3% in the fourth quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company’s stock valued at $25,000 after buying an additional 177 shares during the period. Rialto Wealth Management LLC bought a new stake in Centene in the fourth quarter valued at approximately $30,000. OFI Invest Asset Management bought a new stake in Centene in the fourth quarter valued at approximately $33,000. SRS Capital Advisors Inc. raised its stake in Centene by 73.4% in the fourth quarter. SRS Capital Advisors Inc. now owns 631 shares of the company’s stock valued at $38,000 after buying an additional 267 shares during the period. Finally, Riverview Trust Co increased its stake in shares of Centene by 172.7% during the fourth quarter. Riverview Trust Co now owns 758 shares of the company’s stock worth $46,000 after purchasing an additional 480 shares during the period. Institutional investors own 93.63% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently weighed in on CNC shares. Oppenheimer dropped their price target on Centene from $95.00 to $85.00 and set an “outperform” rating for the company in a report on Friday, December 13th. Wells Fargo & Company dropped their price target on Centene from $76.00 to $72.00 and set an “overweight” rating for the company in a report on Friday, February 14th. StockNews.com cut Centene from a “strong-buy” rating to a “buy” rating in a report on Thursday, February 6th. UBS Group raised Centene from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $79.00 to $80.00 in a report on Friday, December 13th. Finally, Barclays lifted their price target on Centene from $91.00 to $93.00 and gave the stock an “overweight” rating in a report on Friday, December 13th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and ten have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $79.92.

Check Out Our Latest Research Report on CNC

Centene Trading Down 0.7 %

Shares of CNC opened at $59.26 on Thursday. Centene Co. has a 52-week low of $55.03 and a 52-week high of $80.59. The business’s fifty day moving average is $60.39 and its 200-day moving average is $63.43. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.10 and a current ratio of 1.11. The firm has a market cap of $29.40 billion, a price-to-earnings ratio of 9.50, a PEG ratio of 0.80 and a beta of 0.40.

Centene (NYSE:CNCGet Free Report) last issued its quarterly earnings results on Tuesday, February 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.49 by $0.31. Centene had a return on equity of 13.85% and a net margin of 2.03%. The company had revenue of $40.81 billion for the quarter, compared to analyst estimates of $38.78 billion. During the same quarter last year, the company posted $0.45 EPS. The company’s revenue for the quarter was up 3.4% compared to the same quarter last year. Equities analysts anticipate that Centene Co. will post 6.86 EPS for the current fiscal year.

Centene Profile

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.

Featured Articles

Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNCFree Report).

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.